Oxygen Toxicity in the Resuscitation in Extremely Premature Infants (OXTOX)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators hypothesize that using low oxygen concentrations during resuscitation of extremely premature infants will avoid oxidative stress derived damage and improve outcome.
| Condition | Intervention | Phase |
|---|---|---|
|
Birth Asphyxia Premature Birth |
Procedure: Resuscitation |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment |
| Official Title: | Achievement of a Targeted Saturation in Extremely Low Gestational Age Neonates Resuscitated With Low or High Oxygen Concentration: A Prospective Randomized Trial |
- Achievement of a targeted saturation of 85% at 15 min of life. [ Time Frame: 30 min ] [ Designated as safety issue: Yes ]
- Neonatal mortality [ Time Frame: 28 days of life ] [ Designated as safety issue: No ]
- Oxidative stress [ Time Frame: at day 1, 2 and 7 ] [ Designated as safety issue: No ]
- Bronchopulmonary dysplasia [ Time Frame: 36 weeks postconceptional age ] [ Designated as safety issue: No ]
- Retinopathy of prematurity [ Time Frame: 40 weeks postconceptional ] [ Designated as safety issue: No ]
- Neurodevelopment [ Time Frame: 24 months postnatal ] [ Designated as safety issue: No ]
| Enrollment: | 88 |
| Study Start Date: | April 2005 |
| Study Completion Date: | September 2008 |
| Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: LOX
Low saturation group of premature infants that will be kept within preset limits of 85-89%
|
Procedure: Resuscitation
Use of inspiratory fraction of oxygen needed to achieve oxygen saturation in the preset limits 85-88%
|
|
Active Comparator: HOX
HOX group of premature infants will be kept within preset saturation limits of 90-93%
|
Procedure: Resuscitation
Oxygen inspiratory fraction needed to keep oxygen saturation in the preset limits of 90-93%
|
Detailed Description:
This is a prospective randomized trial enrolling premature infants of less than 28 weeks gestation. Patients are randomly assigned to become resuscitation with an initial oxygen inspiratory fraction (FiO2) of 30% or 90%. Main objective is to reach a target saturation of 85% at 15 min of life.
Immediately after birth pre-and-postductal pulse oximeters are set and oxygen saturation (SpO2) continuously monitored and registered as long as the patient requires oxygen supplementation. FiO2 is stepwise adjusted (increased or decreased 10%) every 90 sec according to heart rate, SpO2 and responsiveness.
Blood samples are drawn from umbilical cord and at day 1, 2 and 7 from peripheral vein to determine oxidative stress markers (GSH, GSSG), angiogenic factors (VEGF, VEGF receptors, Angiopoietin), pro-inflammatory markers (IL8, TNF alfa) and pro-apoptotic markers (Fas Ligand; Cytochrome C).
Urine is collected every day during the first week of life to determine oxidative stress markers (8-oxo-dG; O-tyrosine; F2 isoprostanes; Isofurans).
Babies are followed in the NICU and clinical condition recorded. Serial examinations for ROP and Auditory evoked potentials will be performed. Neurodevelopmental outcome is evaluated at 2 years of postnatal life. Main outcome: Achievement of a target saturation of 85% at 15 min of life. Secondary outcomes: acute complications during delivery; chronic complications (BPD, ROP, IPVH); mortality in the neonatal period.
Eligibility| Ages Eligible for Study: | up to 3 Minutes |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Prematurity of less than 28 weeks gestation
Exclusion Criteria:
- Severe malformations
- Chromosomopathies
- Informed consent not signed
Contacts and Locations| Spain | |
| Servicio de Neonatologia | |
| Valencia, Spain, 46009 | |
| Principal Investigator: | Maximo Vento, Phd, Md | Hospital Universitario La Fe |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | INSTITUTO DE SALUD CARLOS III -MINISTERIO DE SANIDAD Y CONSUMO -SPAIN, MAXIMO VENTO |
| ClinicalTrials.gov Identifier: | NCT00494702 History of Changes |
| Other Study ID Numbers: | PIO51O5, FISPI05105 |
| Study First Received: | June 28, 2007 |
| Last Updated: | October 14, 2008 |
| Health Authority: | Spain: Ministry of Health and Consumption |
Keywords provided by Fundacion Para La Investigacion Hospital La Fe:
|
Asphyxia Resuscitation Oxidative stress Prematurity Follow up |
Additional relevant MeSH terms:
|
Asphyxia Asphyxia Neonatorum Premature Birth Death Pathologic Processes |
Wounds and Injuries Infant, Newborn, Diseases Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications |
ClinicalTrials.gov processed this record on May 16, 2013